News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
820,991 Results
Type
Article (69934)
Company Profile (140)
Press Release (750899)
Multimedia
Podcasts (209)
Webinars (29)
Section
Business (221272)
Career Advice (3048)
Deals (37305)
Drug Delivery (163)
Drug Development (89255)
Employer Resources (181)
FDA (17824)
Job Trends (15907)
News (375430)
Policy (35623)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3004)
Academic (2)
Accelerated approval (57)
ADA (48)
Adcomms (40)
Allergies (208)
Alliances (55280)
ALS (239)
Alzheimer's disease (1969)
Antibody-drug conjugate (ADC) (564)
Approvals (18207)
Artificial intelligence (834)
ASCO (344)
Autoimmune disease (362)
Automation (65)
Bankruptcy (351)
Best Places to Work (12267)
BIOSECURE Act (22)
Biosimilars (247)
Biotechnology (108)
Bladder cancer (211)
Brain cancer (85)
Breast cancer (837)
Cancer (6600)
Cardiovascular disease (559)
Career advice (2603)
Career pathing (52)
CAR-T (384)
CDC (75)
Celiac Disease (3)
Cell therapy (1048)
Cervical cancer (56)
Clinical research (77159)
Collaboration (2392)
Commercialization (1)
Company closure (8)
Compensation (1539)
Complete response letters (104)
COVID-19 (3011)
CRISPR (124)
C-suite (1305)
Cystic fibrosis (168)
Data (8784)
Decentralized trials (3)
Denatured (62)
Depression (196)
Dermatology (96)
Diabetes (699)
Diagnostics (7511)
Digital health (68)
Diversity (11)
Diversity, equity & inclusion (44)
Drug discovery (404)
Drug pricing (237)
Drug shortages (38)
Duchenne muscular dystrophy (317)
Earnings (95589)
Editorial (80)
Employer branding (21)
Employer resources (161)
Events (135007)
Executive appointments (1199)
FDA (21926)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (35)
Funding (1945)
Gene editing (270)
Generative AI (80)
Gene therapy (839)
GLP-1 (1270)
Government (5247)
Grass and pollen (8)
Guidances (421)
Healthcare (20620)
Hematology (195)
HIV (95)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (358)
Immuno-oncology (116)
Indications (214)
Infectious disease (3412)
Inflammatory bowel disease (242)
Inflation Reduction Act (16)
Influenza (151)
Intellectual property (325)
Interviews (615)
IPO (17173)
IRA (59)
Job creations (3930)
Job search strategy (2096)
JPM (71)
Kidney cancer (22)
Labor market (113)
Layoffs (677)
Leadership (52)
Legal (8478)
Liver cancer (110)
Longevity (34)
Lung cancer (874)
Lymphoma (481)
Machine learning (68)
Management (63)
Manufacturing (1211)
Marketing (1)
MASH (228)
Medical affairs (1)
Medical device (14852)
Medtech (15021)
Mergers & acquisitions (21499)
Metabolic disorders (1821)
mRNA (267)
Multiple sclerosis (205)
NASH (24)
Neurodegenerative disease (514)
Neuropsychiatric disorders (129)
Neuroscience (3728)
Neurotech (1)
NextGen: Class of 2026 (7091)
Non-profit (4903)
Now hiring (71)
Obesity (869)
Opinion (362)
Ovarian cancer (244)
Pain (285)
Pancreatic cancer (362)
Parkinson's disease (415)
Partnered (40)
Patents (658)
Patient recruitment (775)
Peanut (71)
People (66051)
Pharmaceutical (26)
Pharmacy benefit managers (37)
Phase 1 (24018)
Phase 2 (33707)
Phase 3 (25216)
Pipeline (9932)
Policy (386)
Postmarket research (3106)
Preclinical (10698)
Press Release (71)
Prostate cancer (350)
Psychedelics (72)
Radiopharmaceuticals (371)
Rare diseases (1269)
Real estate (6533)
Recruiting (75)
Regulatory (28017)
Reports (58)
Research institute (2688)
Resumes & cover letters (468)
Rett syndrome (44)
RNA editing (29)
RSV (99)
Schizophrenia (194)
Series A (335)
Series B (242)
Service/supplier (8)
Sickle cell disease (126)
Special edition (31)
Spinal muscular atrophy (187)
Sponsored (51)
Startups (3904)
State (2)
Stomach cancer (21)
Supply chain (141)
Tariffs (104)
The Weekly (144)
Vaccines (1302)
Venture capital (136)
Weight loss (593)
Women's health (137)
Worklife (24)
Date
Today (116)
Last 7 days (480)
Last 30 days (2715)
Last 365 days (32502)
2026 (16638)
2025 (32298)
2024 (37053)
2023 (42187)
2022 (53473)
2021 (58160)
2020 (56716)
2019 (49831)
2018 (37762)
2017 (35066)
2016 (35563)
2015 (41818)
2014 (36245)
2013 (32372)
2012 (34350)
2011 (34497)
2010 (33531)
Location
Africa (1061)
Alabama (97)
Alaska (7)
Arizona (368)
Arkansas (16)
Asia (47960)
Australia (8418)
California (14278)
Canada (4004)
China (1588)
Colorado (614)
Connecticut (632)
Delaware (443)
Europe (110142)
Florida (2146)
Georgia (461)
Hawaii (3)
Idaho (65)
Illinois (1203)
India (102)
Indiana (658)
Iowa (24)
Japan (605)
Kansas (142)
Kentucky (52)
Louisiana (59)
Maine (89)
Maryland (1709)
Massachusetts (10431)
Michigan (416)
Minnesota (777)
Mississippi (7)
Missouri (162)
Montana (36)
Nebraska (31)
Nevada (154)
New Hampshire (92)
New Jersey (3796)
New Mexico (35)
New York (3765)
North Carolina (1890)
North Dakota (10)
Northern California (7206)
Ohio (448)
Oklahoma (27)
Oregon (43)
Pennsylvania (2823)
Puerto Rico (33)
Rhode Island (52)
South America (1413)
South Carolina (88)
South Dakota (2)
Southern California (5661)
Tennessee (230)
Texas (2307)
United States (50954)
Utah (425)
Vermont (2)
Virginia (360)
Washington D.C. (82)
Washington State (1155)
West Virginia (4)
Wisconsin (145)
Wyoming (2)
820,991 Results for "xi an jiaotong university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Restore Robotics Receives FDA 510(k) Clearance for Two Additional da Vinci Xi® Robotic Instruments
April 1, 2026
·
2 min read
Press Releases
Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet
November 10, 2025
·
15 min read
Press Releases
Fresenius Kabi’s Adaptive Nomogram used on Aurora Xi Plasmapheresis System Now Operating Nationwide at BioLife Plasma Centers
November 12, 2025
·
3 min read
Layoffs
50 employees impacted as Astellas closes Universal Cells’ Seattle office
By closing the Universal Cells Seattle location, Astellas is reportedly consolidating cell therapy, gene therapy and oncology research at its South San Francisco, California, and Westborough, Massachusetts, sites.
April 14, 2026
·
2 min read
·
Angela Gabriel
Business
ALLITE® Inc. Partners with Xi’an Jiaotong University to Break New Ground in Magnesium Alloy Material Science
ALLITE® Inc. and Xi’an Jiaotong University will collaborate to pave the way for meaningful discoveries in magnesium alloy research.
January 7, 2020
·
3 min read
Genetown
First-Ever Cost-Effectiveness Analysis of a Factor XI Inhibitor Demonstrates that Abelacimab, if Approved, Could Offer Significant Cost Savings as Compared to a Current Standard of Care Anticoagulant
Results of the first-ever cost-effectiveness study of a Factor XI inhibitor were presented during sessions of the Professional Society for Health Economics and Outcomes Research annual meeting.
May 6, 2024
·
11 min read
Press Releases
BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal
March 5, 2026
·
10 min read
Press Releases
Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma
Clinical Trial Seeks to Validate Novel Blood-Based Assay that Predicts Relapse Risk by Analyzing the Biologic Behavior of Remaining Cancer Cells, Addressing Critical Gaps in Current Minimal Residual Disease (MRD) Testing
April 14, 2026
·
6 min read
Press Releases
John Theurer Cancer Center at Hackensack University Medical Center Presents Innovative Cancer Research at Major Annual Cancer Meeting
May 26, 2026
·
4 min read
Press Releases
Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity
June 3, 2026
·
9 min read
1 of 82,100
Next
